0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Contraceptive Transdermal Patche Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-19O11293
Home | Market Reports | Health| Reproductive Health
Global Contraceptive Transdermal Patche Market Research Report 2022
BUY CHAPTERS

Global Contraceptive Transdermal Patche Market Research Report 2024

Code: QYRE-Auto-19O11293
Report
April 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Contraceptive Transdermal Patche Market

The global Contraceptive Transdermal Patche market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Contraceptive Transdermal Patche is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Contraceptive Transdermal Patche is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Contraceptive Transdermal Patche include Mylan Nv, Ansell Limited, Bayer AG, Church & Dwight Co., Inc., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, The Cooper Companies, Inc. and The Female Health Company, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Contraceptive Transdermal Patche, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptive Transdermal Patche.

Report Scope

The Contraceptive Transdermal Patche market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contraceptive Transdermal Patche market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contraceptive Transdermal Patche manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Contraceptive Transdermal Patche Market Report

Report Metric Details
Report Name Contraceptive Transdermal Patche Market
Segment by Type
  • Progestin-only Contraceptive
  • Combined Hormonal Contraceptive
Segment by Application
  • Hospitals
  • Household
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Mylan Nv, Ansell Limited, Bayer AG, Church & Dwight Co., Inc., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, The Cooper Companies, Inc., The Female Health Company, Abviee Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Contraceptive Transdermal Patche manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Contraceptive Transdermal Patche in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Contraceptive Transdermal Patche Market report?

Ans: The main players in the Contraceptive Transdermal Patche Market are Mylan Nv, Ansell Limited, Bayer AG, Church & Dwight Co., Inc., Merck & Co., Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, The Cooper Companies, Inc., The Female Health Company, Abviee Inc

What are the Application segmentation covered in the Contraceptive Transdermal Patche Market report?

Ans: The Applications covered in the Contraceptive Transdermal Patche Market report are Hospitals, Household, Clinics

What are the Type segmentation covered in the Contraceptive Transdermal Patche Market report?

Ans: The Types covered in the Contraceptive Transdermal Patche Market report are Progestin-only Contraceptive, Combined Hormonal Contraceptive

1 Contraceptive Transdermal Patche Market Overview
1.1 Product Overview and Scope of Contraceptive Transdermal Patche
1.2 Contraceptive Transdermal Patche Segment by Type
1.2.1 Global Contraceptive Transdermal Patche Market Value Comparison by Type (2024-2030)
1.2.2 Progestin-only Contraceptive
1.2.3 Combined Hormonal Contraceptive
1.3 Contraceptive Transdermal Patche Segment by Application
1.3.1 Global Contraceptive Transdermal Patche Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Household
1.3.4 Clinics
1.4 Global Contraceptive Transdermal Patche Market Size Estimates and Forecasts
1.4.1 Global Contraceptive Transdermal Patche Revenue 2019-2030
1.4.2 Global Contraceptive Transdermal Patche Sales 2019-2030
1.4.3 Global Contraceptive Transdermal Patche Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Contraceptive Transdermal Patche Market Competition by Manufacturers
2.1 Global Contraceptive Transdermal Patche Sales Market Share by Manufacturers (2019-2024)
2.2 Global Contraceptive Transdermal Patche Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Contraceptive Transdermal Patche Average Price by Manufacturers (2019-2024)
2.4 Global Contraceptive Transdermal Patche Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Contraceptive Transdermal Patche, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Contraceptive Transdermal Patche, Product Type & Application
2.7 Contraceptive Transdermal Patche Market Competitive Situation and Trends
2.7.1 Contraceptive Transdermal Patche Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Contraceptive Transdermal Patche Players Market Share by Revenue
2.7.3 Global Contraceptive Transdermal Patche Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Contraceptive Transdermal Patche Retrospective Market Scenario by Region
3.1 Global Contraceptive Transdermal Patche Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Contraceptive Transdermal Patche Global Contraceptive Transdermal Patche Sales by Region: 2019-2030
3.2.1 Global Contraceptive Transdermal Patche Sales by Region: 2019-2024
3.2.2 Global Contraceptive Transdermal Patche Sales by Region: 2025-2030
3.3 Global Contraceptive Transdermal Patche Global Contraceptive Transdermal Patche Revenue by Region: 2019-2030
3.3.1 Global Contraceptive Transdermal Patche Revenue by Region: 2019-2024
3.3.2 Global Contraceptive Transdermal Patche Revenue by Region: 2025-2030
3.4 North America Contraceptive Transdermal Patche Market Facts & Figures by Country
3.4.1 North America Contraceptive Transdermal Patche Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Contraceptive Transdermal Patche Sales by Country (2019-2030)
3.4.3 North America Contraceptive Transdermal Patche Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Contraceptive Transdermal Patche Market Facts & Figures by Country
3.5.1 Europe Contraceptive Transdermal Patche Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Contraceptive Transdermal Patche Sales by Country (2019-2030)
3.5.3 Europe Contraceptive Transdermal Patche Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Contraceptive Transdermal Patche Market Facts & Figures by Country
3.6.1 Asia Pacific Contraceptive Transdermal Patche Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Contraceptive Transdermal Patche Sales by Country (2019-2030)
3.6.3 Asia Pacific Contraceptive Transdermal Patche Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Contraceptive Transdermal Patche Market Facts & Figures by Country
3.7.1 Latin America Contraceptive Transdermal Patche Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Contraceptive Transdermal Patche Sales by Country (2019-2030)
3.7.3 Latin America Contraceptive Transdermal Patche Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Contraceptive Transdermal Patche Market Facts & Figures by Country
3.8.1 Middle East and Africa Contraceptive Transdermal Patche Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Contraceptive Transdermal Patche Sales by Country (2019-2030)
3.8.3 Middle East and Africa Contraceptive Transdermal Patche Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Contraceptive Transdermal Patche Sales by Type (2019-2030)
4.1.1 Global Contraceptive Transdermal Patche Sales by Type (2019-2024)
4.1.2 Global Contraceptive Transdermal Patche Sales by Type (2025-2030)
4.1.3 Global Contraceptive Transdermal Patche Sales Market Share by Type (2019-2030)
4.2 Global Contraceptive Transdermal Patche Revenue by Type (2019-2030)
4.2.1 Global Contraceptive Transdermal Patche Revenue by Type (2019-2024)
4.2.2 Global Contraceptive Transdermal Patche Revenue by Type (2025-2030)
4.2.3 Global Contraceptive Transdermal Patche Revenue Market Share by Type (2019-2030)
4.3 Global Contraceptive Transdermal Patche Price by Type (2019-2030)
5 Segment by Application
5.1 Global Contraceptive Transdermal Patche Sales by Application (2019-2030)
5.1.1 Global Contraceptive Transdermal Patche Sales by Application (2019-2024)
5.1.2 Global Contraceptive Transdermal Patche Sales by Application (2025-2030)
5.1.3 Global Contraceptive Transdermal Patche Sales Market Share by Application (2019-2030)
5.2 Global Contraceptive Transdermal Patche Revenue by Application (2019-2030)
5.2.1 Global Contraceptive Transdermal Patche Revenue by Application (2019-2024)
5.2.2 Global Contraceptive Transdermal Patche Revenue by Application (2025-2030)
5.2.3 Global Contraceptive Transdermal Patche Revenue Market Share by Application (2019-2030)
5.3 Global Contraceptive Transdermal Patche Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Mylan Nv
6.1.1 Mylan Nv Corporation Information
6.1.2 Mylan Nv Description and Business Overview
6.1.3 Mylan Nv Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Mylan Nv Contraceptive Transdermal Patche Product Portfolio
6.1.5 Mylan Nv Recent Developments/Updates
6.2 Ansell Limited
6.2.1 Ansell Limited Corporation Information
6.2.2 Ansell Limited Description and Business Overview
6.2.3 Ansell Limited Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ansell Limited Contraceptive Transdermal Patche Product Portfolio
6.2.5 Ansell Limited Recent Developments/Updates
6.3 Bayer AG
6.3.1 Bayer AG Corporation Information
6.3.2 Bayer AG Description and Business Overview
6.3.3 Bayer AG Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer AG Contraceptive Transdermal Patche Product Portfolio
6.3.5 Bayer AG Recent Developments/Updates
6.4 Church & Dwight Co., Inc.
6.4.1 Church & Dwight Co., Inc. Corporation Information
6.4.2 Church & Dwight Co., Inc. Description and Business Overview
6.4.3 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product Portfolio
6.4.5 Church & Dwight Co., Inc. Recent Developments/Updates
6.5 Merck & Co., Inc.
6.5.1 Merck & Co., Inc. Corporation Information
6.5.2 Merck & Co., Inc. Description and Business Overview
6.5.3 Merck & Co., Inc. Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck & Co., Inc. Contraceptive Transdermal Patche Product Portfolio
6.5.5 Merck & Co., Inc. Recent Developments/Updates
6.6 Pfizer Inc.
6.6.1 Pfizer Inc. Corporation Information
6.6.2 Pfizer Inc. Description and Business Overview
6.6.3 Pfizer Inc. Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Inc. Contraceptive Transdermal Patche Product Portfolio
6.6.5 Pfizer Inc. Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Limited
6.6.1 Teva Pharmaceutical Industries Limited Corporation Information
6.6.2 Teva Pharmaceutical Industries Limited Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product Portfolio
6.7.5 Teva Pharmaceutical Industries Limited Recent Developments/Updates
6.8 The Cooper Companies, Inc.
6.8.1 The Cooper Companies, Inc. Corporation Information
6.8.2 The Cooper Companies, Inc. Description and Business Overview
6.8.3 The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.8.4 The Cooper Companies, Inc. Contraceptive Transdermal Patche Product Portfolio
6.8.5 The Cooper Companies, Inc. Recent Developments/Updates
6.9 The Female Health Company
6.9.1 The Female Health Company Corporation Information
6.9.2 The Female Health Company Description and Business Overview
6.9.3 The Female Health Company Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.9.4 The Female Health Company Contraceptive Transdermal Patche Product Portfolio
6.9.5 The Female Health Company Recent Developments/Updates
6.10 Abviee Inc
6.10.1 Abviee Inc Corporation Information
6.10.2 Abviee Inc Description and Business Overview
6.10.3 Abviee Inc Contraceptive Transdermal Patche Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abviee Inc Contraceptive Transdermal Patche Product Portfolio
6.10.5 Abviee Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Contraceptive Transdermal Patche Industry Chain Analysis
7.2 Contraceptive Transdermal Patche Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Contraceptive Transdermal Patche Production Mode & Process
7.4 Contraceptive Transdermal Patche Sales and Marketing
7.4.1 Contraceptive Transdermal Patche Sales Channels
7.4.2 Contraceptive Transdermal Patche Distributors
7.5 Contraceptive Transdermal Patche Customers
8 Contraceptive Transdermal Patche Market Dynamics
8.1 Contraceptive Transdermal Patche Industry Trends
8.2 Contraceptive Transdermal Patche Market Drivers
8.3 Contraceptive Transdermal Patche Market Challenges
8.4 Contraceptive Transdermal Patche Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Contraceptive Transdermal Patche Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Contraceptive Transdermal Patche Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Contraceptive Transdermal Patche Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Contraceptive Transdermal Patche Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Contraceptive Transdermal Patche Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Contraceptive Transdermal Patche Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Contraceptive Transdermal Patche Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Contraceptive Transdermal Patche Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Contraceptive Transdermal Patche, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Contraceptive Transdermal Patche, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Contraceptive Transdermal Patche, Product Type & Application
    Table 12. Global Key Manufacturers of Contraceptive Transdermal Patche, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Contraceptive Transdermal Patche by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Contraceptive Transdermal Patche as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Contraceptive Transdermal Patche Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Contraceptive Transdermal Patche Sales by Region (2019-2024) & (K Units)
    Table 18. Global Contraceptive Transdermal Patche Sales Market Share by Region (2019-2024)
    Table 19. Global Contraceptive Transdermal Patche Sales by Region (2025-2030) & (K Units)
    Table 20. Global Contraceptive Transdermal Patche Sales Market Share by Region (2025-2030)
    Table 21. Global Contraceptive Transdermal Patche Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Contraceptive Transdermal Patche Revenue Market Share by Region (2019-2024)
    Table 23. Global Contraceptive Transdermal Patche Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Contraceptive Transdermal Patche Revenue Market Share by Region (2025-2030)
    Table 25. North America Contraceptive Transdermal Patche Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Contraceptive Transdermal Patche Sales by Country (2019-2024) & (K Units)
    Table 27. North America Contraceptive Transdermal Patche Sales by Country (2025-2030) & (K Units)
    Table 28. North America Contraceptive Transdermal Patche Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Contraceptive Transdermal Patche Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Contraceptive Transdermal Patche Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Contraceptive Transdermal Patche Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Contraceptive Transdermal Patche Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Contraceptive Transdermal Patche Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Contraceptive Transdermal Patche Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Contraceptive Transdermal Patche Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Contraceptive Transdermal Patche Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Contraceptive Transdermal Patche Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Contraceptive Transdermal Patche Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Contraceptive Transdermal Patche Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Contraceptive Transdermal Patche Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Contraceptive Transdermal Patche Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Contraceptive Transdermal Patche Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Contraceptive Transdermal Patche Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Contraceptive Transdermal Patche Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Contraceptive Transdermal Patche Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Contraceptive Transdermal Patche Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Contraceptive Transdermal Patche Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Contraceptive Transdermal Patche Sales (K Units) by Type (2019-2024)
    Table 51. Global Contraceptive Transdermal Patche Sales (K Units) by Type (2025-2030)
    Table 52. Global Contraceptive Transdermal Patche Sales Market Share by Type (2019-2024)
    Table 53. Global Contraceptive Transdermal Patche Sales Market Share by Type (2025-2030)
    Table 54. Global Contraceptive Transdermal Patche Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Contraceptive Transdermal Patche Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2019-2024)
    Table 57. Global Contraceptive Transdermal Patche Revenue Market Share by Type (2025-2030)
    Table 58. Global Contraceptive Transdermal Patche Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Contraceptive Transdermal Patche Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Contraceptive Transdermal Patche Sales (K Units) by Application (2019-2024)
    Table 61. Global Contraceptive Transdermal Patche Sales (K Units) by Application (2025-2030)
    Table 62. Global Contraceptive Transdermal Patche Sales Market Share by Application (2019-2024)
    Table 63. Global Contraceptive Transdermal Patche Sales Market Share by Application (2025-2030)
    Table 64. Global Contraceptive Transdermal Patche Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Contraceptive Transdermal Patche Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Contraceptive Transdermal Patche Revenue Market Share by Application (2019-2024)
    Table 67. Global Contraceptive Transdermal Patche Revenue Market Share by Application (2025-2030)
    Table 68. Global Contraceptive Transdermal Patche Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Contraceptive Transdermal Patche Price (US$/Unit) by Application (2025-2030)
    Table 70. Mylan Nv Corporation Information
    Table 71. Mylan Nv Description and Business Overview
    Table 72. Mylan Nv Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Mylan Nv Contraceptive Transdermal Patche Product
    Table 74. Mylan Nv Recent Developments/Updates
    Table 75. Ansell Limited Corporation Information
    Table 76. Ansell Limited Description and Business Overview
    Table 77. Ansell Limited Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Ansell Limited Contraceptive Transdermal Patche Product
    Table 79. Ansell Limited Recent Developments/Updates
    Table 80. Bayer AG Corporation Information
    Table 81. Bayer AG Description and Business Overview
    Table 82. Bayer AG Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Bayer AG Contraceptive Transdermal Patche Product
    Table 84. Bayer AG Recent Developments/Updates
    Table 85. Church & Dwight Co., Inc. Corporation Information
    Table 86. Church & Dwight Co., Inc. Description and Business Overview
    Table 87. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Church & Dwight Co., Inc. Contraceptive Transdermal Patche Product
    Table 89. Church & Dwight Co., Inc. Recent Developments/Updates
    Table 90. Merck & Co., Inc. Corporation Information
    Table 91. Merck & Co., Inc. Description and Business Overview
    Table 92. Merck & Co., Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Merck & Co., Inc. Contraceptive Transdermal Patche Product
    Table 94. Merck & Co., Inc. Recent Developments/Updates
    Table 95. Pfizer Inc. Corporation Information
    Table 96. Pfizer Inc. Description and Business Overview
    Table 97. Pfizer Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Pfizer Inc. Contraceptive Transdermal Patche Product
    Table 99. Pfizer Inc. Recent Developments/Updates
    Table 100. Teva Pharmaceutical Industries Limited Corporation Information
    Table 101. Teva Pharmaceutical Industries Limited Description and Business Overview
    Table 102. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Teva Pharmaceutical Industries Limited Contraceptive Transdermal Patche Product
    Table 104. Teva Pharmaceutical Industries Limited Recent Developments/Updates
    Table 105. The Cooper Companies, Inc. Corporation Information
    Table 106. The Cooper Companies, Inc. Description and Business Overview
    Table 107. The Cooper Companies, Inc. Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. The Cooper Companies, Inc. Contraceptive Transdermal Patche Product
    Table 109. The Cooper Companies, Inc. Recent Developments/Updates
    Table 110. The Female Health Company Corporation Information
    Table 111. The Female Health Company Description and Business Overview
    Table 112. The Female Health Company Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. The Female Health Company Contraceptive Transdermal Patche Product
    Table 114. The Female Health Company Recent Developments/Updates
    Table 115. Abviee Inc Corporation Information
    Table 116. Abviee Inc Description and Business Overview
    Table 117. Abviee Inc Contraceptive Transdermal Patche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Abviee Inc Contraceptive Transdermal Patche Product
    Table 119. Abviee Inc Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Contraceptive Transdermal Patche Distributors List
    Table 123. Contraceptive Transdermal Patche Customers List
    Table 124. Contraceptive Transdermal Patche Market Trends
    Table 125. Contraceptive Transdermal Patche Market Drivers
    Table 126. Contraceptive Transdermal Patche Market Challenges
    Table 127. Contraceptive Transdermal Patche Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Contraceptive Transdermal Patche
    Figure 2. Global Contraceptive Transdermal Patche Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Contraceptive Transdermal Patche Market Share by Type in 2023 & 2030
    Figure 4. Progestin-only Contraceptive Product Picture
    Figure 5. Combined Hormonal Contraceptive Product Picture
    Figure 6. Global Contraceptive Transdermal Patche Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Contraceptive Transdermal Patche Market Share by Application in 2023 & 2030
    Figure 8. Hospitals
    Figure 9. Household
    Figure 10. Clinics
    Figure 11. Global Contraceptive Transdermal Patche Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Contraceptive Transdermal Patche Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Contraceptive Transdermal Patche Sales (2019-2030) & (K Units)
    Figure 14. Global Contraceptive Transdermal Patche Average Price (US$/Unit) & (2019-2030)
    Figure 15. Contraceptive Transdermal Patche Report Years Considered
    Figure 16. Contraceptive Transdermal Patche Sales Share by Manufacturers in 2023
    Figure 17. Global Contraceptive Transdermal Patche Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Contraceptive Transdermal Patche Players: Market Share by Revenue in 2023
    Figure 19. Contraceptive Transdermal Patche Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Contraceptive Transdermal Patche Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Contraceptive Transdermal Patche Sales Market Share by Country (2019-2030)
    Figure 22. North America Contraceptive Transdermal Patche Revenue Market Share by Country (2019-2030)
    Figure 23. United States Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Contraceptive Transdermal Patche Sales Market Share by Country (2019-2030)
    Figure 26. Europe Contraceptive Transdermal Patche Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Contraceptive Transdermal Patche Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Contraceptive Transdermal Patche Revenue Market Share by Region (2019-2030)
    Figure 34. China Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. China Taiwan Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Contraceptive Transdermal Patche Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Contraceptive Transdermal Patche Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Contraceptive Transdermal Patche Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Contraceptive Transdermal Patche Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. UAE Contraceptive Transdermal Patche Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Contraceptive Transdermal Patche by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Contraceptive Transdermal Patche by Type (2019-2030)
    Figure 55. Global Contraceptive Transdermal Patche Price (US$/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Contraceptive Transdermal Patche by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Contraceptive Transdermal Patche by Application (2019-2030)
    Figure 58. Global Contraceptive Transdermal Patche Price (US$/Unit) by Application (2019-2030)
    Figure 59. Contraceptive Transdermal Patche Value Chain
    Figure 60. Contraceptive Transdermal Patche Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart